SOX7 and acute lymphoblastic leukemia: To evaluate the role of SOX7 in BCP-ALL, we therefore used two shRNAs conferring around 50% decrease in SOX7 transcript levels in RS4;11 and NALM6 expressing intermediate and high SOX7 level respectively (Figure 3A–3B).